Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ana Maria Martin Moreno"'
Autor:
Omar Saavedra Santa Gadea, Elena Elez, R. Berché, Cristina Saura, Maria del Mar Villar, Honey Kumar Oberoi, Ignacio Matos, Vladimir Galvao, Carlota Arenillas, Ana Maria Martin Moreno, Ana Oaknin, Guzman Alonso, Enriqueta Felip, Josep Tabernero, Rodrigo A. Toledo, Eva Muñoz-Couselo, Natassia Ann Wornham, Irene Brana, Elena Garralda, Javier Ros
Publikováno v:
Journal of Clinical Oncology. 39:2542-2542
2542 Background: Detection of ctDNA is a promising tool for managing pts in oncology. Most methods require whole-genome sequencing of tumor samples followed by the design of personalized panels for tracking purposes. In this work, we evaluated the pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::24e88e01031d48e67e849bf919bc972f
https://doi.org/10.1200/jco.2021.39.15_suppl.2542
https://doi.org/10.1200/jco.2021.39.15_suppl.2542
Autor:
Mariana Bastos, Mario Gutiérrez Rodríguez, Azueg Hong, Gilberto Barranco, Juan-Manuel Sancho, José María Sánchez-Pina, Raul Cordoba, Jordi Martinez-Serra, Mónica Baile, Silvana Novelli, Ana Maria Martin Moreno, Alejandro Martín, Antonio Díaz-López, Pau Abrisqueta, Jose Rodriguez, Leyre Bento, Hugo Daniel Luzardo Henriquez, Daniel F. Garcia, Antonio Gutierrez, Sonia González de Villambrosia, Maria J. Rodriguez-Salazar, Marta Garcia Recio, Raquel Del Campo, Olga García, Antonio Salar
Publikováno v:
Blood. 132:347-347
Introduction DLBCL is the most common non-Hodgkin lymphoma and a heterogeneous subtype from the biological and clinical point of view. 20-40% of the patients relapse so it is important to identify a high risk population that could benefit from differ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::645988be26ac386092d41fe928e4264c
https://doi.org/10.1182/blood-2018-99-118719
https://doi.org/10.1182/blood-2018-99-118719
Autor:
Víctor Abraira, José Antonio Queizán, Antonio Gutierrez, Lourdes Lopez, Heidys Garrote, Jordina Rovira, Ruben Fernandez, José Morales Sánchez, Sonia González de Villambrosia, Mónica Baile, Leyre Bento, Carlos Montalbán, Raul Cordoba, Ana Maria Martin Moreno, Ivan Dlouhy, Juan-Manuel Sancho, Juan F. García, Julian Freue, Silvana Novelli, Mariana Bastos, Raquel de Oña, Mario Gutiérrez Rodríguez, Antonio Díaz-López, Juan F. Dominguez, Maria J. Rodriguez-Salazar, Armando López-Guillermo, Alejandro Martín, Olga García, Antonio Salar, Jose Rodriguez
Publikováno v:
Blood. 130:827-827
Introduction Diffuse large B cell lymphoma (DLBCL) is a heterogeneous group of aggressive B cell lymphomas, considering their biologic, pathological and clinical backgrounds. However, treatment of DLBCL is relatively homogeneous and standard, mainly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5288239692debaa98d94aa33dee26092
https://doi.org/10.1182/blood.v130.suppl_1.827.827
https://doi.org/10.1182/blood.v130.suppl_1.827.827
Autor:
Ernesto Roldan Santiago, Javier López-Jiménez, Ana Maria Martin Moreno, P. González-Porqué, Marı́a Luisa Villar, Garbiñe Roy, Constantino Cespón, Carmen Cámara, Rosario Luque, A. Bootello
Publikováno v:
Blood. 97(1)
Tumoral lymphocytes from patients with B-chronic lymphocytic leukemia (B-CLL) are long-lived cells in vivo, but they die rapidly by apoptosis in vitro. Here, it is reported that endothelial cells (ECs) inhibit the apoptosis of B-CLL cells, as determi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b826da47ea20b9c9554aa20190013815
https://pubmed.ncbi.nlm.nih.gov/11133767
https://pubmed.ncbi.nlm.nih.gov/11133767
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.